Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy

Publisher： Karger

E-ISSN： 1662-6575|9|1|195-204

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.1, 2016-03, pp. : 195-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 376-381

Karger

Access to resources Recommend Favorite

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 238-246

Karger

Access to resources Recommend Favorite

Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

By Mastroianni Candida M.  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

Improvement of Oral Intake following Chemotherapy in Gastric Cancer Patients with an Inability to Eat

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 211-218

Karger

Access to resources Recommend Favorite

Improved Overall Survival with 12 Cycles of Single-Agent Paclitaxel Maintenance Therapy following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 389-393

Karger

Access to resources Recommend Favorite